Business Description
Monopar Therapeutics is a US-based clinical-stage company focused on developing new treatments for cancer and other serious diseases. Its pipeline includes an oral daily medication for Wilson disease licensed from Alexion, as well as a targeted antibody-based therapy designed to seek out and destroy advanced solid tumors. The company is also advancing a suite of imaging and therapeutic agents that use radioactive materials attached to this antibody to both locate and treat tumors more precisely. Founded in 2014 and based in Wilmette, Illinois, Monopar works alongside partners such as NorthStar and Excel Diagnostics to bring these treatments closer to patients.
